KEGG   DRUG: Tobevibart
Entry
D12631                      Drug                                   
Name
Tobevibart (USAN/INN)
Formula
C6356H9846N1698O1988S42
Exact mass
143112.9822
Mol weight
143201.1002
Sequence
(Heavy chain)
ELQLVESGGG WVQPGGSQRL SCAASGRIFR SFYMSWVRQA PGKGLEWVAT INQDGSEKLY
VDSVKGRFTI SRDNAKNSLF LQMNNLRVED TAVYYCAAWS GNSGGMDVWG QGTTVSVSSA
STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKKVEPK SCDKTHTCPP CPAPELLAGP
SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS
TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PLPEEKTISK AKGQPREPQV YTLPPSRDEL
TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ
QGNVFSCSVL HEALHSHYTQ KSLSLSPGK
(Light chain)
SYELTQPPSV SVSPGQTVSI PCSGDKLGNK NVAWFQHKPG QSPVLVIYEV KYRPSGIPER
FSGSNSGNTA TLTISGTQAM DEAAYFCQTF DSTTVVFGGG TRLTVLGQPK AAPSVTLFPP
SSEELQANKA TLVCLISDFY PGAVTVAWKA DSSPVKAGVE TTTPSKQSNN KYAASSYLSL
TPEQWKSHRS YSCQVTHEGS TVEKTVAPTE CS
(Disulfide bridge: H22-H96, H146-H202, H222-L211, H228-H'228, H231-H'231, H263-H323, H369-H427, H'22-H'96, H'146-H'202, H'222-L'211, H'263-H'323, H'369-H'427, L22-L87, L134-L193, L'22-L'87, L'134-L'193)
  Type
Peptide
Efficacy
Antiviral
  Type
Monoclonal antibody
Comment
Treatment of chronic HBV infection and chronic HBV and HDV coinfection
Target
HBV surface antigen [KO:K23128]
  Pathway
ko03230  Viral genome structure
ko05161  Hepatitis B
Brite
Antimicrobials [BR:br08307]
 Antivirals
  Entry, fusion or uncoating inhibitor
   Hepatitis virus antigen
    D12631  Tobevibart (USAN/INN)
Other DBs
CAS: 2645440-65-7
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system